GenoScreen, founded in 2001, is an innovation-driven biotech company in the field of microbial genomics and bioinformatics. We develop, manufacture and market molecular tools and analytical solutions for biomedicine, microbiome science, live biotherapeutics, cosmetics, and agri/agro-food. Our solutions are used in more than 80 countries by world leading players in academia, industry, hospital, pharmaceutical and other institutions.
Our flagship product, Deeplex Myc-TB kit, is one of the most comprehensive commercial molecular tests for detection of anti-TB-drug resistance available to date. Based on Next Generation Sequencing, this culture-free assay allows TB detection and antibiotic resistance prediction in less than 48 hours. With our deep sequencing product portfolio, our goal is to become a key player leader in IVD tools for infectious diseases and detection of antimicrobial resistance.
